Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical practice guidelines for severe renal hyperparathyroidism].

Yoshihiro Tominaga1

  • 1Department Surgery, Renal center, Nagoya 2nd Red Cross Hospital.

Clinical Calcium
|December 4, 2004
PubMed
Summary

Parathyroidectomy (PTX) may treat severe hyperparathyroidism in chronic kidney disease (CKD) patients. However, clear biomedical criteria for this surgery are needed to define appropriate indications for surgical treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy.

Frontiers in endocrinology·2023
Same author

Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.

Frontiers in endocrinology·2023
Same author

Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism.

Frontiers in medicine·2022
Same author

Renal hyperparathyroidism.

Vitamins and hormones·2022
Same author

Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.

BMC nephrology·2022
Same author

Preservation of the nonrecurrent laryngeal nerve using intraoperative nerve monitoring during endoscopic thyroidectomy.

Asian journal of endoscopic surgery·2022

Area of Science:

  • Nephrology
  • Endocrinology
  • Surgical Oncology

Context:

  • Clinical practice guidelines suggest parathyroidectomy (PTX) for severe hyperparathyroidism in chronic kidney disease (CKD).
  • Indications include persistent high serum i-PTH (> 800 pg/mL) with refractory hypercalcemia/hyperphosphatemia.
  • Current guidelines lack well-defined criteria and supporting studies for PTX indications.

Purpose:

  • To highlight the need for clinical studies to establish precise biomedical criteria for parathyroidectomy in CKD patients.
  • To review the effectiveness of surgical interventions for severe secondary hyperparathyroidism.

Summary:

  • Severe secondary hyperparathyroidism in CKD patients may be treated with parathyroidectomy (PTX).
  • Guidelines suggest PTX for persistent hyperparathyroidism refractory to medical management.
  • Further clinical research is essential to define optimal surgical indications and criteria.

Impact:

  • This research underscores the necessity for evidence-based criteria to guide surgical decisions in managing hyperparathyroidism in CKD.
  • Clarifying indications for PTX can optimize patient outcomes and resource allocation in nephrology and endocrine surgery.
  • Effective surgical management, including subtotal or total PTX with autograft, is confirmed for severe secondary hyperparathyroidism.

Related Experiment Videos